Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis-Reference-Cited by-同舟云学术

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis

Published:2020-03 Issue:3 Volume:36 Page:322-334
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Fine Nowell M.,Davis Margot K.,Anderson Kim^ORCID,Delgado Diego H.,Giraldeau Genevieve,Kitchlu Abhijat^ORCID,Massie Rami^ORCID,Narayan Jane,Swiggum Elizabeth^ORCID,Venner Christopher P.,Ducharme Anique^ORCID,Galant Natalie J.^ORCID,Hahn Christopher,Howlett Jonathan G.^ORCID,Mielniczuk Lisa,Parent Marie-Claude^ORCID,Reece Donna,Royal Virginie^ORCID,Toma Mustafa,Virani Sean A.^ORCID,Zieroth Shelley^ORCID

Funder

Canadian Cardiovascular Society

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study;Tanskanen;Ann Med,2008

2. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction;Gonzalez-Lopez;Eur Heart J,2015

3. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement;Castano;Eur Heart J,2017

4. Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness;Damy;Eur Heart J,2016

5. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis;Maurer;Circ Heart Fail,2019

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic presentation of family members of ATTRv probands and subsequent disease penetrance;2024-09-07

2. Thromboembolic and bleeding risk in cardiac amyloidosis;Journal of Thrombosis and Haemostasis;2024-09

3. ASNC Quality Metrics for Cardiac Amyloid Radionuclide Imaging;Journal of Nuclear Cardiology;2024-09

4. Non-Immunoglobulin Amyloidosis-Mediated Kidney Disease: Emerging Understanding of Underdiagnosed Entities;Advances in Kidney Disease and Health;2024-07

5. Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis;Heart Failure Clinics;2024-07